Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents
Of 41 children, adolescents, and young adults who were withdrawn from chronic neuroleptic treatment, 18 developed tardive dyskinesia, withdrawal dyskinesia, nondyskinetic withdrawal symptoms, or transient behavior deterioration. Development of neuroleptic-related problems seemed to be associated wit...
Gespeichert in:
| Veröffentlicht in: | The American journal of psychiatry 1984-01, Vol.141 (1), p.20-23 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 23 |
|---|---|
| container_issue | 1 |
| container_start_page | 20 |
| container_title | The American journal of psychiatry |
| container_volume | 141 |
| creator | GUALTIERI, C. T QUADE, D HICKS, R. E MAYO, J. P SCHROEDER, S. R |
| description | Of 41 children, adolescents, and young adults who were withdrawn from
chronic neuroleptic treatment, 18 developed tardive dyskinesia, withdrawal
dyskinesia, nondyskinetic withdrawal symptoms, or transient behavior
deterioration. Development of neuroleptic-related problems seemed to be
associated with cumulative neuroleptic dose and possibly with the sex of
the subject. Only 12 of the 41 subjects required resumption of neuroleptic
treatment after a prolonged trial withdrawal period. |
| doi_str_mv | 10.1176/ajp.141.1.20 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1310610019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1310610019</sourcerecordid><originalsourceid>FETCH-LOGICAL-a377t-29bf055ffafcb7e954311d27ceaffc3d9750c375aba2a874a1b965ed4924da533</originalsourceid><addsrcrecordid>eNptkE1r3DAQhkVJSbZpb70GBOmlUG80kmWtjyH0CwK9pJCbGEujRluv7EreQP591e4SeuhpGN6Hd4aHsbcg1gCmu8LtvIYW1rCW4gVbgVa6MVJuTthKCCGbXqv7M_aqlG1dhTLylJ120IpNp1fsxx1mHx-J-6fyMyYqETkmz6flgTJ3Y0zR4cjdlAr92lNyVPgUeKJ9nkaal-j4kgmXHaWFx8TdQxx9pvS3BH1liqtRec1eBhwLvTnOc_b908e7my_N7bfPX2-ubxtUxiyN7IcgtA4BgxsM9bpVAF4aRxiCU743WjhlNA4ocWNahKHvNPm2l61HrdQ5uzz0znmq_5bFbqd9TvWkBQWiAyGgr9SHA-XyVEqmYOccd5ifLAj7R6qtUm2VasFKUfGLY-l-2JF_ho8Wa_7umGOptkLG5GJ5xvoWOinair0_YDjP8Z-__nfyN3zzjnE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1310610019</pqid></control><display><type>article</type><title>Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents</title><source>MEDLINE</source><source>Psychiatry Legacy Collection Online Journals 1844-1996</source><source>Periodicals Index Online</source><creator>GUALTIERI, C. T ; QUADE, D ; HICKS, R. E ; MAYO, J. P ; SCHROEDER, S. R</creator><creatorcontrib>GUALTIERI, C. T ; QUADE, D ; HICKS, R. E ; MAYO, J. P ; SCHROEDER, S. R</creatorcontrib><description>Of 41 children, adolescents, and young adults who were withdrawn from
chronic neuroleptic treatment, 18 developed tardive dyskinesia, withdrawal
dyskinesia, nondyskinetic withdrawal symptoms, or transient behavior
deterioration. Development of neuroleptic-related problems seemed to be
associated with cumulative neuroleptic dose and possibly with the sex of
the subject. Only 12 of the 41 subjects required resumption of neuroleptic
treatment after a prolonged trial withdrawal period.</description><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/ajp.141.1.20</identifier><identifier>PMID: 6140865</identifier><identifier>CODEN: AJPSAO</identifier><language>eng</language><publisher>Washington, DC: American Psychiatric Publishing</publisher><subject>Adolescent ; Adult ; Age Factors ; Antipsychotic Agents - administration & dosage ; Antipsychotic Agents - adverse effects ; Biological and medical sciences ; Child ; Child clinical studies ; Child, Preschool ; Dose-Response Relationship, Drug ; Dyskinesia, Drug-Induced - etiology ; Female ; Follow-Up Studies ; Humans ; Intellectual Disability - drug therapy ; Intellectual Disability - psychology ; Male ; Medical sciences ; Mental Disorders - drug therapy ; Mental Disorders - psychology ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Sex Factors ; Substance Withdrawal Syndrome - etiology</subject><ispartof>The American journal of psychiatry, 1984-01, Vol.141 (1), p.20-23</ispartof><rights>1984 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a377t-29bf055ffafcb7e954311d27ceaffc3d9750c375aba2a874a1b965ed4924da533</citedby><cites>FETCH-LOGICAL-a377t-29bf055ffafcb7e954311d27ceaffc3d9750c375aba2a874a1b965ed4924da533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/ajp.141.1.20$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/ajp.141.1.20$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>314,780,784,2859,4024,21629,27869,27923,27924,27925,77791,77792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=9416204$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6140865$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GUALTIERI, C. T</creatorcontrib><creatorcontrib>QUADE, D</creatorcontrib><creatorcontrib>HICKS, R. E</creatorcontrib><creatorcontrib>MAYO, J. P</creatorcontrib><creatorcontrib>SCHROEDER, S. R</creatorcontrib><title>Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents</title><title>The American journal of psychiatry</title><addtitle>Am J Psychiatry</addtitle><description>Of 41 children, adolescents, and young adults who were withdrawn from
chronic neuroleptic treatment, 18 developed tardive dyskinesia, withdrawal
dyskinesia, nondyskinetic withdrawal symptoms, or transient behavior
deterioration. Development of neuroleptic-related problems seemed to be
associated with cumulative neuroleptic dose and possibly with the sex of
the subject. Only 12 of the 41 subjects required resumption of neuroleptic
treatment after a prolonged trial withdrawal period.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Antipsychotic Agents - administration & dosage</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child clinical studies</subject><subject>Child, Preschool</subject><subject>Dose-Response Relationship, Drug</subject><subject>Dyskinesia, Drug-Induced - etiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Intellectual Disability - drug therapy</subject><subject>Intellectual Disability - psychology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mental Disorders - drug therapy</subject><subject>Mental Disorders - psychology</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Sex Factors</subject><subject>Substance Withdrawal Syndrome - etiology</subject><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>K30</sourceid><recordid>eNptkE1r3DAQhkVJSbZpb70GBOmlUG80kmWtjyH0CwK9pJCbGEujRluv7EreQP591e4SeuhpGN6Hd4aHsbcg1gCmu8LtvIYW1rCW4gVbgVa6MVJuTthKCCGbXqv7M_aqlG1dhTLylJ120IpNp1fsxx1mHx-J-6fyMyYqETkmz6flgTJ3Y0zR4cjdlAr92lNyVPgUeKJ9nkaal-j4kgmXHaWFx8TdQxx9pvS3BH1liqtRec1eBhwLvTnOc_b908e7my_N7bfPX2-ubxtUxiyN7IcgtA4BgxsM9bpVAF4aRxiCU743WjhlNA4ocWNahKHvNPm2l61HrdQ5uzz0znmq_5bFbqd9TvWkBQWiAyGgr9SHA-XyVEqmYOccd5ifLAj7R6qtUm2VasFKUfGLY-l-2JF_ho8Wa_7umGOptkLG5GJ5xvoWOinair0_YDjP8Z-__nfyN3zzjnE</recordid><startdate>19840101</startdate><enddate>19840101</enddate><creator>GUALTIERI, C. T</creator><creator>QUADE, D</creator><creator>HICKS, R. E</creator><creator>MAYO, J. P</creator><creator>SCHROEDER, S. R</creator><general>American Psychiatric Publishing</general><general>American Psychiatric Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>HAWNG</scope><scope>HBMBR</scope><scope>IBDFT</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope></search><sort><creationdate>19840101</creationdate><title>Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents</title><author>GUALTIERI, C. T ; QUADE, D ; HICKS, R. E ; MAYO, J. P ; SCHROEDER, S. R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a377t-29bf055ffafcb7e954311d27ceaffc3d9750c375aba2a874a1b965ed4924da533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Antipsychotic Agents - administration & dosage</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child clinical studies</topic><topic>Child, Preschool</topic><topic>Dose-Response Relationship, Drug</topic><topic>Dyskinesia, Drug-Induced - etiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Intellectual Disability - drug therapy</topic><topic>Intellectual Disability - psychology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mental Disorders - drug therapy</topic><topic>Mental Disorders - psychology</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Sex Factors</topic><topic>Substance Withdrawal Syndrome - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GUALTIERI, C. T</creatorcontrib><creatorcontrib>QUADE, D</creatorcontrib><creatorcontrib>HICKS, R. E</creatorcontrib><creatorcontrib>MAYO, J. P</creatorcontrib><creatorcontrib>SCHROEDER, S. R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 13</collection><collection>Periodicals Index Online Segment 14</collection><collection>Periodicals Index Online Segment 27</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access & Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access & Build (Plan A) - APAC</collection><collection>Primary Sources Access & Build (Plan A) - Canada</collection><collection>Primary Sources Access & Build (Plan A) - West</collection><collection>Primary Sources Access & Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - Midwest</collection><collection>Primary Sources Access & Build (Plan A) - North Central</collection><collection>Primary Sources Access & Build (Plan A) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GUALTIERI, C. T</au><au>QUADE, D</au><au>HICKS, R. E</au><au>MAYO, J. P</au><au>SCHROEDER, S. R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents</atitle><jtitle>The American journal of psychiatry</jtitle><addtitle>Am J Psychiatry</addtitle><date>1984-01-01</date><risdate>1984</risdate><volume>141</volume><issue>1</issue><spage>20</spage><epage>23</epage><pages>20-23</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><coden>AJPSAO</coden><abstract>Of 41 children, adolescents, and young adults who were withdrawn from
chronic neuroleptic treatment, 18 developed tardive dyskinesia, withdrawal
dyskinesia, nondyskinetic withdrawal symptoms, or transient behavior
deterioration. Development of neuroleptic-related problems seemed to be
associated with cumulative neuroleptic dose and possibly with the sex of
the subject. Only 12 of the 41 subjects required resumption of neuroleptic
treatment after a prolonged trial withdrawal period.</abstract><cop>Washington, DC</cop><pub>American Psychiatric Publishing</pub><pmid>6140865</pmid><doi>10.1176/ajp.141.1.20</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-953X |
| ispartof | The American journal of psychiatry, 1984-01, Vol.141 (1), p.20-23 |
| issn | 0002-953X 1535-7228 |
| language | eng |
| recordid | cdi_proquest_journals_1310610019 |
| source | MEDLINE; Psychiatry Legacy Collection Online Journals 1844-1996; Periodicals Index Online |
| subjects | Adolescent Adult Age Factors Antipsychotic Agents - administration & dosage Antipsychotic Agents - adverse effects Biological and medical sciences Child Child clinical studies Child, Preschool Dose-Response Relationship, Drug Dyskinesia, Drug-Induced - etiology Female Follow-Up Studies Humans Intellectual Disability - drug therapy Intellectual Disability - psychology Male Medical sciences Mental Disorders - drug therapy Mental Disorders - psychology Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Sex Factors Substance Withdrawal Syndrome - etiology |
| title | Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A55%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tardive%20dyskinesia%20and%20other%20clinical%20consequences%20of%20neuroleptic%20treatment%20in%20children%20and%20adolescents&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=GUALTIERI,%20C.%20T&rft.date=1984-01-01&rft.volume=141&rft.issue=1&rft.spage=20&rft.epage=23&rft.pages=20-23&rft.issn=0002-953X&rft.eissn=1535-7228&rft.coden=AJPSAO&rft_id=info:doi/10.1176/ajp.141.1.20&rft_dat=%3Cproquest_cross%3E1310610019%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1310610019&rft_id=info:pmid/6140865&rfr_iscdi=true |